date,title,source
Oct-26-18,"Market Trends Toward New Normal in Ascendis Pharma A/S, Diodes, Laureate Education, Randgold Resources, Fastenal, and LTC Properties  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Nov-08-18,Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon Endocrinology Rare Disease Therapies in China,GlobeNewswire
Nov-28-18,Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-28-18,Ascendis Pharma A/S Announces Positive Preliminary Phase 1 Data for TransCon CNP,GlobeNewswire
Dec-12-18,Should You Buy Ascendis Pharma A/S (ASND)?,Insider Monkey
Dec-21-18,Ascendis Pharma A/S Announces Participation in 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-07-19,Ascendis Pharma A/S Introduces Vision 3x3: A Strategic Roadmap Through 2025 to Achieve Sustainable Growth Using Multiple Approaches,GlobeNewswire
Jan-09-19,Edited Transcript of ASND earnings conference call or presentation 28-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Jan-17-19,Edited Transcript of ASND earnings conference call or presentation 28-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Jan-25-19,All You Need to Know About Ascendis Pharma A/S (ASND) Rating Upgrade to Buy,Zacks
